Somatus Achieves 4-Star Rating for Health Plan Partner Kidney Population Through Whole-Person Clinical Quality Program by Seini Moimoi | Jun 12, 2024 | Portfolio News
Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease by Seini Moimoi | Jun 11, 2024 | Portfolio News
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC by Seini Moimoi | Jun 6, 2024 | Portfolio News
Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study by Seini Moimoi | Jun 4, 2024 | Portfolio News
Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation by Seini Moimoi | Jun 4, 2024 | Portfolio News
Bolt Medical Announces Results of First 60 Patients in RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System by Seini Moimoi | May 29, 2024 | Portfolio News
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN) by Seini Moimoi | May 28, 2024 | Portfolio News
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis by Seini Moimoi | May 19, 2024 | Portfolio News
89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis by Seini Moimoi | May 14, 2024 | Portfolio News
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs by Seini Moimoi | May 7, 2024 | Portfolio News
